Abstract
Purpose :
To describe clinical and OCT findings in patients with epiretinal membranes.
Methods :
The medical records of patients with epirretinal membranes diagnosed by retinologists using contemporary OCT-SD Heidelberg studies and patients with epirretinal membrane diagnosed by imaging but not clinically between June 2015 and July 2017 were retrospectively analyzed.
Results :
One hundred sixteen (116) eyes of eighty six patients (86) were included. Mean age was 71.18 years (38-93 years) and they were predominantly Caucasian.
Vision loss was the most common symptom (40%), followed by blurred vision (11%), myodesopsia (11%), metamorphopsia (6%), photopsia (4%) and diplopia (2%), while 26% of the patients were asymptomatic.
93,11% of the ERMs had funduscopic and OCT diagnosis; while 6.89% were diagnosed using OCT. Epiretinal membranes thickness determined by Heidelberg OCT-SD was over 320nm in 74% of the sample; corresponding to GAS 1 and GAS 2 stadiums.
Ellipsoide zone appeared to be continuous (undisrupted) in 50% of the cases while the other 50% could be described as discontinuous or disrupted.
Pseudophakic patients developed more likely epirretinal membranes, 36% of patients referring ocular disease history suffering macular pucker were pseudo phakic, followed by glaucoma (16%), retinal detachment (6%), uveitis (5%), thrombosis (3%), maculopathy (3%)and diabetic retinopathy (2%).
Macular edema appeared to be the most common complication (53,94%), followed by VPD (22.36%), macular hole (7%), pseudo macular hole (9.21) and hemorrhage (5.26%).
Conclusions :
OCT has proven to be a very sensitive study for ERM diagnosis. An important percentage remains asymptomatic at the moment of the medical consultation. More emphasis in the funduscopic exam should be given to patients with previous cataract surgery. It is difficult to underline clinical and tomographic correlations because of the lack of a tomographic consensous for its classification.
This is an abstract that was submitted for the 2018 ARVO Annual Meeting, held in Honolulu, Hawaii, April 29 - May 3, 2018.